BCTG Acquisition Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 7 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
BCTG Acquisition Corp
TickerTNGX
CIK #0001819133
CUSIP87583X109
SectorReal Estate & Construction - Blank Checks
Address12860 El Camino Real, Suite 300, San Diego, CA 92130
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Tango Therapeutics Inc 2025-10-28 15.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001819133] 10-K
[0001819133] 10-Q
[0001819133] 3
[0001819133] 4
[0001819133] 8-K
[0001819133] D
[0001819133] SC 13D
[0001819133] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
RTW Investments LP Tango Therapeutics Inc [2026-05-15] 0.0
FMR LLC Tango Therapeutics Inc [2026-05-06] 0.0
Adage Capital Management LP Tango Therapeutics Inc [2026-02-12] 0.0
Vanguard Group Inc Tango Therapeutics Inc [2026-01-30] 0.0
BlackRock Inc Tango Therapeutics Inc [2026-01-21] 0.0
Woodline Partners LP Tango Therapeutics Inc [2025-08-14] 0.0
Adage Capital Management LP Tango Therapeutics Inc [2025-08-12] 0.0
BlackRock Inc Tango Therapeutics Inc [2025-07-17] 0.0
Farallon Capital Partners LP Tango Therapeutics Inc [2025-06-13] 0.0
TCG Crossover GP II LLC Tango Therapeutics Inc [2024-11-20] 81949.8
EcoR1 Capital LLC Tango Therapeutics Inc [2023-09-21] 7.7
Nextech Crossover I GP Sa RL Tango Therapeutics Inc [2023-08-21] 5.4
Southpoint Capital Advisors LP Tango Therapeutics Inc [2022-07-11] 5.1
Cormorant Asset Management LP Tango Therapeutics Inc [2022-02-14] 5.6
FMR LLC Tango Therapeutics Inc [2022-02-09] 0.0
Gilead Sciences Inc Tango Therapeutics Inc [2021-09-10] 5.5
BCTG Holdings LLC Tango Therapeutics Inc [2021-08-20] 8.3
Third Rock Ventures IV LP Tango Therapeutics Inc [2021-08-19] 22.1
Casdin Capital LLC Tango Therapeutics Inc [2021-08-19] 6.3
Southpoint Capital Advisors LP BCTG Acquisition Corp [2021-04-26] 8.9
RA Capital Management LP BCTG Acquisition Corp [2021-02-16] 5.8
BCTG Holdings LLC BCTG Acquisition Corp [2021-02-16] 21.0
Form 3/4/5 Filer 2011 - 2026
Tango Therapeutics Inc
Crystal Adam
Azelby Robert
Ketchum John B
Lee Sung
Rothenberg Mace
Calhoun Lesley Ann
Gall Matthew
Newcomb Jessica
Weber Barbara
Beckman Daniella
Peters Malte
Third Rock Ventures GP IV LP
Third Rock Ventures IV LP
TRV GP IV LLC
Borisy Alexis
Barry Douglas
EcoR1 Capital LLC
Davis Aaron I
Boxer Capital Management LLC
MVA Investors LLC
Pothula Kanishka
Lewis Joseph
Boxer Asset Management Inc
Boxer Capital LLC
Third Rock Ventures GP VI LP
Third Rock Ventures VI LP
TRV GP VI LLC
Huber Reid M
Huang Alan
Weitzman Aaron
Braslyn Ltd
Blueprint Medicines Corp
Rudoltz Marc
BCTG Holdings LLC
Avery James B
Fuglesang Christopher
Heyman Richard A
Nuechterlein Carole
Beauchamp Michael
Ellis Andrew Ruel
Christensen Jamie
BAUM Charles M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Crystal Adam
Common Stock
2026-03-25 Sell 12,000 $20.11 241,320
Crystal Adam
Stock Option (Right to Buy) · derivative
2026-03-25 Option exercise 12,000 $0.00
Crystal Adam
Common Stock
2026-03-25 Option exercise 12,000 $5.20 62,400
Crystal Adam
Common Stock
2026-03-05 Sell 20,251 $15.00 303,765
Crystal Adam
Common Stock
2026-02-25 Sell 54,345 $12.77 693,986
Crystal Adam
Common Stock
2026-02-03 Sell 18,251 $12.26 223,757
Crystal Adam
Common Stock
2026-02-03 Sell 201 $12.90 2,593
Beckman Daniella
Common Stock
2026-02-03 Sell 10,204 $12.26 125,101
Beckman Daniella
Common Stock
2026-02-03 Sell 113 $12.90 1,458
Weber Barbara
Common Stock
2026-02-03 Sell 333 $12.90 4,296
Weber Barbara
Common Stock
2026-02-03 Sell 30,186 $12.26 370,080
Beckman Daniella
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 265,980 $0.00
Crystal Adam
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 284,760 $0.00
Beckman Daniella
Common Stock
2026-02-02 Grant 44,330 $0.00
Weber Barbara
Common Stock
2026-02-02 Grant 37,522 $0.00
Crystal Adam
Common Stock
2026-02-02 Grant 47,460 $0.00
Weber Barbara
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 222,132 $0.00
Peters Malte
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 1,650,000 $0.00
Peters Malte
Common Stock
2026-01-08 Grant 350,000 $0.00
Lee Sung
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 60,000 $0.00
showing 20 of 177 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 195 178,531,733
2025-12-31 171 171,326,022
2025-09-30 141 135,953,034
2025-06-30 115 123,814,485
2025-03-31 123 103,288,170
2024-12-31 139 102,397,202
2024-09-30 122 95,790,920
2024-06-30 120 93,203,698
2024-03-31 127 93,857,698
2023-12-31 122 92,862,187
2023-09-30 101 88,108,446
2023-06-30 90 67,613,218
Form 13F Holdings
Firm Period DFND Voting Shares
Congress Asset Management Co [2026-06-30] SOLE 336,446 380,746
Assenagon Asset Management SA [2026-06-30] SOLE 345,156 345,156
TEMA ETFS LLC [2026-06-30] SOLE 55,384 55,384
PSP Research LLC [2026-06-30] SOLE 0 10,000
Gamma Investing LLC [2026-06-30] DFND 863 863
Farther Finance Advisors LLC [2026-06-30] SOLE 0 377
Fortitude Family Office LLC [2026-06-30] SOLE 310 310
Handelsbanken Fonder AB [2026-06-30] SOLE 0 287
LRI Investments LLC [2026-06-30] SOLE 236 236
IFP Advisors LLC [2026-06-30] SOLE 210 210
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 18
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 8 8
Hughes Financial Services LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com